Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2855-2026

Nerivio Infinity. Recall

Nerivio Infinity. Model/Catalog Number: FGD000100. Software Version: FW Version 4.1.2.0, App version 7.28.0.11

FDA recall Class II

Ongoing

FDA lists this Class II recall for Nerivio Infinity.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2855-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Mar 23, 2026
FDA report date
Aug 12, 2026
Quantity in commerce
11,886 units
Distribution
See key details
FDA cause
Component design/selection

What is being recalled?

Nerivio Infinity. Model/Catalog Number: FGD000100. Software Version: FW Version 4.1.2.0, App version 7.28.0.11

Affected model & UDI checker

Search the exact identifiers published for Z-2855-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
FGD000100Nerivio Infinity.Check source noticeNot specified
Not specifiedNerivio Infinity.Check source notice7290017578118
FDA code information

Model/Catalog Number: FGD000100. UDI: 01072900175781181125120221NI2544-0300673 Software Version: FW Version 4.1.2.0, App version 7.28.0.11 GTIN: 7290017578118. Serial Number: NI2544-0300673.

View the original FDA recall notice

Why was this product recalled?

Potential for the batter to have a thermal-runway event during charging, resulting in smoke and odor.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did THERANICA BIOELECTRONICS LTD take?

Firm issued a stop ship of product from distributors starting March 22, 2026 after learning of the reported event. These devices were released from hold on 4/30/2026, after the device firmware update was released on 4/19/26. Starting May 13, 2026, customers received in-app messaging which ensure that all affected users receive instructions regarding the required corrective action. Users were prompted to perform a software update affecting both the mobile application used to control the device and the device firmware. The firmware update permanently disables the device upon detection of an overheating event. The software update provides an enhanced warning mechanism if it detects a device malfunction.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology